These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7659590)

  • 41. Left ventricular sensing and pacing for sensing difficulties in internal cardioverter defibrillator therapy for arrhythmogenic right ventricular cardiomyopathy.
    Lochy S; François B; Hollanders G; Provenier F
    Europace; 2010 Aug; 12(8):1195-6. PubMed ID: 20348554
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heart rate turbulence predicts ICD-resistant mortality in ischaemic heart disease.
    Marynissen T; Floré V; Heidbuchel H; Nuyens D; Ector J; Willems R
    Europace; 2014 Jul; 16(7):1069-77. PubMed ID: 24196450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of noninvasive programmed stimulation for initiating ventricular tachyarrhythmias in patients with third-generation implantable cardioverter defibrillators.
    Kleiman RB; Callans DJ; Hook BG; Marchlinski FE
    Pacing Clin Electrophysiol; 1994 Sep; 17(9):1462-8. PubMed ID: 7991416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inappropriate sensing of pectoral myopotentials by an implantable cardioverter defibrillator system.
    Karanam S; John RM
    Pacing Clin Electrophysiol; 2004 May; 27(5):688-9. PubMed ID: 15125734
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lead system causing twiddler's syndrome in patients with an implantable cardioverter-defibrillator.
    Bracke F; van Gelder B; Dijkman B; Meijer A
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):231-2. PubMed ID: 15632856
    [No Abstract]   [Full Text] [Related]  

  • 46. Troubleshooting implantable cardioverter defibrillator system malfunctions: the role of impedance measurements.
    Haddad L; Padula LE; Moreau M; Schoenfeld MH
    Pacing Clin Electrophysiol; 1994 Sep; 17(9):1456-61. PubMed ID: 7991415
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic value of single versus dual chamber electrograms recorded from an implantable defibrillator.
    Kim MH; Bruckman D; Sticherling C; Oral H; Pelosi F; Knight BP; Morady F; Strickberger SA
    J Interv Card Electrophysiol; 2003 Aug; 9(1):49-53. PubMed ID: 12975572
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Automatic R-wave and impedance testing with the modern patient alert system to reduce inappropriate implantable cardioverter defibrillator shocks due to lead fracture.
    Chinushi M; Hosaka Y; Ikarashi N; Iijima K; Furushima H; Aizawa Y
    Europace; 2008 Jun; 10(6):738-40. PubMed ID: 18390874
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inappropriate implantable cardioverter defibrillator shock from a transcutaneous muscle stimulation device therapy.
    Siu CW; Tse HF; Lau CP
    J Interv Card Electrophysiol; 2005 Jun; 13(1):73-5. PubMed ID: 15976983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications.
    Ellenbogen KA; Wood MA; Shepard RK; Clemo HF; Vaughn T; Holloman K; Dow M; Leffler J; Abeyratne A; Verness D
    J Am Coll Cardiol; 2003 Jan; 41(1):73-80. PubMed ID: 12570948
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [An unusual series of complications in therapy with implantable cardioverter-defibrillator].
    Peters W; Hopp H; Bauer WR; Kowallik P; Meesmann M
    Z Kardiol; 1995 Apr; 84(4):296-300. PubMed ID: 7785302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Significance of supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators.
    Schmitt C; Montero M; Melichercik J
    Pacing Clin Electrophysiol; 1994 Mar; 17(3 Pt 1):295-302. PubMed ID: 7513854
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and testing of an algorithm to detect implantable cardioverter-defibrillator lead failure.
    Gunderson BD; Gillberg JM; Wood MA; Vijayaraman P; Shepard RK; Ellenbogen KA
    Heart Rhythm; 2006 Feb; 3(2):155-62. PubMed ID: 16443529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ICD lead parameters, performance, and adverse events following continuous-flow LVAD implantation.
    Thomas IC; Cork DP; Levy A; Nayak H; Beshai JF; Burke MC; Moss JD
    Pacing Clin Electrophysiol; 2014 Apr; 37(4):464-72. PubMed ID: 24237034
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cardioverter-defibrillator implantation in the heart catheterization laboratory--observations with 105 patients].
    Trappe HJ; Pfitzner P; Heintze J; Kielblock B; Wenzlaff P; Fieguth HG; Panning B; Lichtlen PR
    Z Kardiol; 1995 May; 84(5):385-93. PubMed ID: 7625101
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Measurement of ventricular electrogram amplitude during intraoperative induction of ventricular tachyarrhythmias.
    Ellenbogen KA; Wood MA; Stambler BS; Welch WJ; Damiano RJ
    Am J Cardiol; 1992 Oct; 70(11):1017-22. PubMed ID: 1414898
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator.
    Kelly PA; Mann DE; Damle RS; Reiter MJ
    J Am Coll Cardiol; 1994 Jun; 23(7):1531-4. PubMed ID: 8195509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Initial clinical results with a novel implantable cardioverter-defibrillator: a prospective evaluation in 3 Swiss university hospitals].
    Osswald S; Candinas R; Fuhrer J
    Schweiz Med Wochenschr; 1995 Dec; 125(50):2423-32. PubMed ID: 8553030
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sensing/pacing lead complications with a newer generation implantable cardioverter-defibrillator: worldwide experience from the Guardian ATP 4210 clinical trial.
    Stambler BS; Wood MA; Damiano RJ; Greenway PS; Smutka ML; Ellenbogen KA
    J Am Coll Cardiol; 1994 Jan; 23(1):123-32. PubMed ID: 8277070
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of longevity and clinical outcomes of implantable cardioverter-defibrillator leads among manufacturers.
    Kawada S; Nishii N; Morimoto Y; Miyoshi A; Tachibana M; Sugiyama H; Nakagawa K; Watanabe A; Morita H; Ito H
    Heart Rhythm; 2017 Oct; 14(10):1496-1503. PubMed ID: 28502870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.